glp-1 reimbursement news Medicare Drug Coverage LegitScript's Data Reveals 1200% Increase

This can help restart the weight loss process

and Indianapolis-based Eli Lilly, which makes Zepbound, agreed to sell their drugs to Medicare at a lower most favored nation rate, as well as offer discounts directly to other consumers on the TrumpRx website that will launch in early 2026

52 LinM.ChengP.HsiaoP.ChenS.HungC.KuoC.et al (2023)

Glucagon-like peptide-1 acutely affects renal blood flow and urinary flow rate in spontaneously hypertensive rats despite significantly reduced renal expression of GLP-1 receptors

For many people, nausea is most noticeable during the first few weeks after starting treatment and after dose increases

The rising prevalence of diabetes is expected to propel the GLP-1 receptor agonist market going forward